The 2009 Import and Export Market for Heterocyclic Compounds with Nitrogen Hetero-Atom(s) Only, Containing a Pyrimidine Ring, Piperazine Ring, or ... Ring, and Nucleic Acids and Salts in Europe

On the demand side, exporters and strategic planners approaching the market in Europe face a number of questions. Which countries are supplying heterocyclic compounds with nitrogen hetero-atom(s) only, containing a pyrimidine ring, piperazine ring, or unfused triazine ring, and nucleic acids and salts to Europe? What is the dollar value of these imports? How much do the imports of heterocyclic compounds with nitrogen hetero-atom(s) only, containing a pyrimidine ring, piperazine ring, or unfused triazine ring, and nucleic acids and salts vary from one country to another in Europe? Do exporters serving the market in Europe have similar market shares across the importing countries? On the supply side, Europe also sells to the international market of heterocyclic compounds with nitrogen hetero-atom(s) only, containing a pyrimidine ring, piperazine ring, or unfused triazine ring, and nucleic acids and salts. Which countries in Europe supply the most exports of heterocyclic compounds with nitrogen hetero-atom(s) only, containing a pyrimidine ring, piperazine ring, or unfused triazine ring, and nucleic acids and salts? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers? This report was created for strategic planners, international marketing executives and import/export managers who are concerned with the market for heterocyclic compounds with nitrogen hetero-atom(s) only, containing a pyrimidine ring, piperazine ring, or unfused triazine ring, and nucleic acids and salts in Europe. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for heterocyclic compounds with nitrogen hetero-atom(s) only, containing a pyrimidine ring, piperazine ring, or unfused